Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
AkhvwDLKTwbUKgsb
